German  |  English
Features for this Premium Statistic
 

Do you have a question or a suggestion for this statistic? Please visit our contact page.
More statistics about...
 
You may also be interested in...
 
We are celebrating
 
International Year of Statistics 2013Statistics have powerful and far-reaching effects on everyone, yet most people are unaware of their connection and how statistics improve their lives. 2013 is the International Year of Statistics, a worldwide event supported by nearly 1,900 organizations - and we are part of it!learn more
Recommended Websites
 

Do you know of an interesting website related to this topic? Suggest here

Novartis' top drugs based on revenue 2012 (fee-based)

 

Novartis AG's top 10 drugs based on revenue in 2012 (in million U.S. dollars)

Do you want to view this graph? Sign up for a Premium Account and benefit from the following extras:

  • Quick and convenient access to all statistics
  • More than 1.5 million statistics and facts
  • All data downloadable in PPT, XLS and JPG format

Get Account Source Get Account


© Statista 2013

Reading support:
This statistic depicts Novartis AG's top 10 drugs based on revenue in 2012. Novartis is a Swiss-based global pharmaceutical company. In 2012, Novartis' drug Tasigna generated some 998 million U.S. dollars of revenues.

Statistic Information
 
Survey
Survey by  Get Account
Survey time period 2012
Object of investigation Novartis' top drugs
Region Worldwide
Macroregion Trans-Continental only (with GER)
Type Ranking
Category business company, business volume
Relevance 4
Release
Published by  Get Account
Source link  Get Account
Release date January 2013
Further information  Get Account
Popular statistics
 
Viewed by other users
 
Latest statistics
 
Related reports
 
to: drug, revenue, Novartis
How you can access Statista